Merck Swings To 4Q Loss On Charges; Issues Weak Outlook
February 03, 2011 at 09:40 AM EST
Merck & Co. (MRK) swung to a fourth-quarter loss on a writedown of the value of an experimental heart drug recently linked to safety concerns, while the drug maker abandoned its prior long-term profit forecast, citing the drug setback and market pressures.
